Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-03140 in PTSD
NCT01492699Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Jun 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PRX-03140 in post-traumatic stress disorder (PTSD), sponsored by Resilience Government Services. Started Jun 2012; status: completed.
02
Drugs
PRX-03140
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01492699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01492699.